1. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis*. (1st June 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis. (1st June 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis. (22nd February 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Fumaric acid esters in combination with a 6‐week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate‐to‐severe plaque psoriasis: a randomized prospective clinical study. (1st March 2018) Authors: Tzaneva, S.; Geroldinger, A.; Trattner, H.; Tanew, A. Journal: British journal of dermatology Issue: Volume 178:Number 3(2018) Page Start: 682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Fumaric acid esters in combination with a 6‐week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate‐to‐severe plaque psoriasis: a randomized prospective clinical study. (1st March 2018) Authors: Tzaneva, S.; Geroldinger, A.; Trattner, H.; Tanew, A. Journal: British journal of dermatology Issue: Volume 178:Number 3(2018) Page Start: e233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Fumaric acid esters in combination with a 6‐week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate‐to‐severe plaque psoriasis: a randomized prospective clinical study. (31st January 2018) Authors: Tzaneva, S.; Geroldinger, A.; Trattner, H.; Tanew, A. Journal: British journal of dermatology Issue: Volume 178:Number 3(2018) Page Start: 682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Fumaric acid esters in combination with a 6‐week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate‐to‐severe plaque psoriasis: a randomized prospective clinical study. (29th March 2018) Authors: Tzaneva, S.; Geroldinger, A.; Trattner, H.; Tanew, A. Journal: British journal of dermatology Issue: Volume 178:Number 3(2018) Page Start: e233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Quality of life and comorbidities in palmoplantar pustulosis – a cross‐sectional study on 102 patients. (11th July 2017) Authors: Trattner, H.; Blüml, S.; Steiner, I.; Plut, U.; Radakovic, S.; Tanew, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 10(2017) Page Start: 1681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 对中度至重度斑块状银屑病患者采用延胡索酸酯并配合为期六周的窄带紫外线B疗法比单独采用延胡索酸酯治疗的效果更加有效:一项随机前瞻性临床研究. (1st March 2018) Authors: Tzaneva, S.; Geroldinger, A.; Trattner, H.; Tanew, A. Journal: British journal of dermatology Issue: Volume 178:Number 3(2018) Page Start: e247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 对中度至重度斑块状银屑病患者采用延胡索酸酯并配合为期六周的窄带紫外线B疗法比单独采用延胡索酸酯治疗的效果更加有效:一项随机前瞻性临床研究. (29th March 2018) Authors: Tzaneva, S.; Geroldinger, A.; Trattner, H.; Tanew, A. Journal: British journal of dermatology Issue: Volume 178:Number 3(2018) Page Start: e247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗